Skip to main content
. Author manuscript; available in PMC: 2019 Jan 22.
Published in final edited form as: Neuropharmacology. 2017 Nov 8;129:36–46. doi: 10.1016/j.neuropharm.2017.11.012

Fig. 8.

Fig. 8

Effects of acute discontinuation of twice-daily methamphetamine on 5-CSRTT performance. For each group, the data labeled ‘Pre’ were collected in a normal daily session, after which methamphetamine was not administered. Data labeled ‘D1-PM’ were collected in the afternoon session the following day; 5.6 mg/kg RO5263397 was administered prior to this session in the right panel. See Figure 5, left for ordinates and abscissas.